Mojtaba Shafiekhani
- Co-authors
- Afsaneh VazinMahtabalsadat MirjaliliManica NegahdaripourMohammad Mehdi OmmatiNegar AzarpiraReza HeidariIman KarimzadehReza Shahriarirad
- Topics
- COVID-19 Clinical Research Studies (9 papers)Clinical Nutrition and Gastroenterology (9 papers)Antibiotics Pharmacokinetics and Efficacy (7 papers)
- Journals
- SHILAP Revista de lepidopterologíaScientific ReportsTransplantation
- Partner nations
- IranArgentinaUnited States
In The Last Decade
Mojtaba Shafiekhani
45 papers receiving 332 citations
Peers
Comparison fields: 5 of 96
- Infectious Diseases 117
- Epidemiology 46
- Surgery 45
- Pharmacology 36
- Nutrition and Dietetics 31
Countries citing papers authored by Mojtaba Shafiekhani
This map shows the geographic impact of Mojtaba Shafiekhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojtaba Shafiekhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojtaba Shafiekhani more than expected).
Fields of papers citing papers by Mojtaba Shafiekhani
This network shows the impact of papers produced by Mojtaba Shafiekhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojtaba Shafiekhani. The network helps show where Mojtaba Shafiekhani may publish in the future.
Co-authorship network of co-authors of Mojtaba Shafiekhani
This figure shows the co-authorship network connecting the top 25 collaborators of Mojtaba Shafiekhani. A scholar is included among the top collaborators of Mojtaba Shafiekhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mojtaba Shafiekhani. Mojtaba Shafiekhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 10 | |
| 10 | 9 | |
| 11 | 0 | |
| 12 | 21 | |
| 13 | Comparison of Ceftizoxime Plus Ampicillin-Sulbactam versus Gentamicin Plus Ampicillin-Sulbactam in the Prevention of Post-Transplant Early Bacterial Infections in Liver Transplant Recipients: A Randomized Controlled Trial | 0 |
| 14 | Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen | 3 |
| 15 | 4 | |
| 16 | 29 | |
| 17 | Glycine supplementation mitigates lead-induced renal injury in mice | 3 |
| 18 | 5 | |
| 19 | 3 | |
| 20 | 14 |
About Mojtaba Shafiekhani
Mojtaba Shafiekhani is a scholar working on Transplantation, Applied Microbiology and Biotechnology and Microbiology, having authored 51 papers that have together received 336 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (9 papers), Clinical Nutrition and Gastroenterology (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). The work is most often cited by research in Transplantation (28 citations), Applied Microbiology and Biotechnology (19 citations) and Infectious Diseases (117 citations). Mojtaba Shafiekhani has collaborated with scholars based in Iran, Argentina and United States. Frequent co-authors include Afsaneh Vazin, Mahtabalsadat Mirjalili, Manica Negahdaripour, Mohammad Mehdi Ommati, Negar Azarpira, Reza Heidari, Iman Karimzadeh, Reza Shahriarirad, Soha Namazi and Dorna Davani-Davari. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.